Back to User profile » Dr Stephen Harnicar

Papers published by Dr Stephen Harnicar:

Review

Entrectinib: an orally available, selective tyrosine kinase inhibitor for the treatment of NTRK, ROS1, and ALK fusion-positive solid tumors

Liu D, Offin M, Harnicar S, Li BT, Drilon A

Therapeutics and Clinical Risk Management 2018, 14:1247-1252

Published Date: 20 July 2018

Review

Spotlight on nilotinib in the treatment of chronic myelogenous leukemia

Harnicar S, Mathew S

Blood and Lymphatic Cancer: Targets and Therapy 2014, 4:61-67

Published Date: 21 August 2014